BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shao L, Shen S, Liu H. Recent advances in PLGA micro/nanoparticle delivery systems as novel therapeutic approach for drug-resistant tuberculosis. Front Bioeng Biotechnol 2022;10:941077. [DOI: 10.3389/fbioe.2022.941077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Valdemar-Aguilar CM, Manisekaran R, Acosta-Torres LS, López-Marín LM. Spotlight on mycobacterial lipid exploitation using nanotechnology for diagnosis, vaccines, and treatments. Nanomedicine 2023;48:102653. [PMID: 36646193 DOI: 10.1016/j.nano.2023.102653] [Reference Citation Analysis]
2 Bourguignon T, Godinez-Leon JA, Gref R. Nanosized Drug Delivery Systems to Fight Tuberculosis. Pharmaceutics 2023;15. [PMID: 36839715 DOI: 10.3390/pharmaceutics15020393] [Reference Citation Analysis]
3 Acharya AP, Sezginel KB, Gideon HP, Greene AC, Lawson HD, Inamdar S, Tang Y, Fraser AJ, Patel KV, Liu C, Rosi NL, Chan SY, Flynn JL, Wilmer CE, Little SR. In silico identification and synthesis of a multi-drug loaded MOF for treating tuberculosis. J Control Release 2022;352:242-55. [PMID: 36273529 DOI: 10.1016/j.jconrel.2022.10.024] [Reference Citation Analysis]